RBC Capital Downgrades Valeant Pharmaceuticals (VRX) to Sector Perform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. SPY
10. FISV

Go back to RBC Capital Downgrades Valeant Pharmaceuticals (VRX) to Sector Perform

UPDATE: Canaccord Genuity Downgrades Valeant Pharmaceuticals (VRX) to Hold

March 2, 2016 6:55 AM EST

(Updated - March 2, 2016 1:08 PM EST)

Canaccord Genuity downgraded Valeant Pharmaceuticals (NYSE: VRX) from Buy to Hold and lowered its price target to $75 (from $125). Valeant recently confirmed that it has several ongoing investigations, including investigations by the US Attorneys Offices for Massachusetts and the Southern District of New York, the SEC, and Congress.

Analyst Neil Maruoka commented... More

Valeant Pharma (VRX) Pares Earlier Decline

March 1, 2016 2:28 PM EST

Valeant Pharma (NYSE: VRX) pared earlier declines to trade lower by only 1.3%.

... More

Valeant (VRX) PT Cut to $106 at Jefferies

March 1, 2016 8:16 AM EST

Jefferies analyst David Steinberg lowered his price target on Valeant Pharmaceuticals (NYSE: VRX) to $106.00 (from $172.00) while maintaining a Buy rating.

Steinberg commented, "With the return of CEO Mike Pearson, a critical issue has been addressed. However, a host of equally critical questions have... More

Valeant Pharma (VRX) Provides Statement on SEC Investigation

February 29, 2016 4:41 PM EST

Valeant Pharma (NYSE: VRX) said:

"In response to media inquiries, Valeant confirmed that it has several ongoing investigations, including investigations by the US Attorneys Offices for Massachusetts and the Southern District of New York, the SEC, and Congress. With respect to the SEC... More

Valeant Pharma (VRX) Affirms Receipt of SEC Subpoena

February 29, 2016 4:40 PM EST

Valeant Pharma (NYSE: VRX) issued the following statement on Monday:

"In response to media inquiries, Valeant confirmed that it has several ongoing investigations, including investigations by the US Attorneys Offices for Massachusetts and the Southern District of New York, the SEC, and... More

Valeant Pharma (VRX) Says It's Under Investigation by SEC

February 29, 2016 3:36 PM EST

(Updated - February 29, 2016 3:38 PM EST)

Valeant Pharma (NYSE: VRX) said it's under investigation by the SEC, according to Bloomberg, citing spokesperson Laurie Little. The probe is said to be separate from the Salix investigation.

"In response to media inquiries, Valeant confirmed that it... More